Mary F Mulcahy Selected Research

Biosimilar Pharmaceuticals

1/2021

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary F Mulcahy Research Topics

Disease

69	Neoplasms (Cancer) 01/2023 - 01/2005
27	Hepatocellular Carcinoma (Hepatoma) 10/2018 - 09/2005
17	Neoplasm Metastasis (Metastasis) 12/2021 - 09/2005
14	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2002
9	Adenocarcinoma 01/2023 - 10/2011
8	Colonic Neoplasms (Colon Cancer) 01/2021 - 06/2002
8	Pancreatic Neoplasms (Pancreatic Cancer) 08/2014 - 09/2005
7	Rectal Neoplasms (Rectal Cancer) 12/2023 - 12/2004
6	Fatigue 01/2022 - 01/2010
5	Nausea 01/2022 - 01/2010
5	Necrosis 12/2016 - 03/2007
4	Microsatellite Instability 01/2023 - 01/2008
4	Cholangiocarcinoma 08/2022 - 10/2008
4	Hypoxia (Hypoxemia) 08/2011 - 11/2005
4	Fibrosis (Cirrhosis) 08/2011 - 09/2005
3	Carcinoma (Carcinomatosis) 01/2023 - 04/2012
3	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 05/2018
3	Disease Progression 01/2019 - 01/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2019 - 05/2011
3	Weight Loss (Weight Reduction) 01/2013 - 02/2006
3	Abdominal Pain (Pain, Abdominal) 07/2012 - 02/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 01/2011
2	Diarrhea 01/2020 - 07/2012
2	Pathologic Complete Response 01/2020 - 11/2012
2	Neutropenia 01/2020 - 01/2005
2	Liver Neoplasms (Liver Cancer) 07/2014 - 05/2008
2	Pain (Aches) 04/2014 - 01/2010
2	Pneumonia (Pneumonitis) 12/2013 - 10/2011
2	Liver Diseases (Liver Disease) 07/2012 - 07/2005
2	Vomiting 07/2012 - 01/2010
2	End Stage Liver Disease 12/2006 - 09/2005
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Liposarcoma 01/2022
1	Wounds and Injuries (Trauma) 12/2020
1	Leukopenia 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Obesity 01/2020
1	Esophageal Squamous Cell Carcinoma 05/2018
1	Squamous Cell Carcinoma of Head and Neck 03/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2016

Drug/Important Bio-Agent (IBA)

30	Yttrium-90IBA 08/2022 - 09/2005
9	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 06/2002
9	Bevacizumab (Avastin)FDA Link 01/2020 - 07/2005
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
7	Leucovorin (Folinic Acid)FDA Link 01/2020 - 06/2002
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 07/2005
6	Gemcitabine FDA Link 08/2014 - 02/2006
5	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2005
5	YttriumIBA 08/2013 - 09/2005
5	BilirubinIBA 07/2012 - 01/2008
4	AlbuminsIBA 10/2014 - 01/2010
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2012 - 12/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 06/2002
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2005
3	Monoclonal AntibodiesIBA 05/2007 - 07/2005
2	B7-H1 AntigenIBA 01/2023 - 01/2022
2	Cetuximab (Erbitux)FDA Link 01/2020 - 03/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2008
2	Thymidylate SynthaseIBA 01/2018 - 01/2008
2	Capecitabine (Xeloda)FDA Link 01/2017 - 04/2014
2	thiamine triphosphorate (TTP)IBA 09/2016 - 06/2010
2	Trastuzumab (Herceptin)FDA Link 02/2015 - 05/2013
2	Sorafenib (BAY 43-9006)FDA Link 08/2014 - 08/2011
2	Transcription Factors (Transcription Factor)IBA 10/2008 - 05/2007
2	Polyvinyl AlcoholIBA 05/2007 - 11/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2007 - 07/2005
1	cixutumumabIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Serum AlbuminIBA 08/2022
1	selinexorIBA 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 12/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	taxaneIBA 01/2019
1	Drug CombinationsIBA 01/2019
1	PlatinumIBA 01/2019
1	EnzymesIBA 05/2018
1	Messenger RNA (mRNA)IBA 05/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2018
1	VemurafenibIBA 04/2018
1	veliparibIBA 01/2017

Therapy/Procedure

63	Therapeutics 12/2023 - 06/2002
25	Drug Therapy (Chemotherapy) 12/2023 - 06/2002
19	Microspheres (Microsphere) 01/2019 - 09/2005
15	Radiotherapy 10/2022 - 09/2005
6	Neoadjuvant Therapy 10/2022 - 10/2011
4	Chemoradiotherapy 12/2023 - 10/2011
4	Aftercare (After-Treatment) 10/2013 - 03/2007
4	Radiofrequency Ablation 09/2009 - 09/2005
3	Transplantation 08/2014 - 12/2006
2	Adjuvant Chemotherapy 12/2013 - 06/2002
2	Injections 10/2013 - 07/2006
2	Liver Transplantation 12/2006 - 09/2005
1	Operative Time 12/2020
1	Infusion Pumps (Infusion Pump) 12/2020
1	Length of Stay 12/2020
1	Secondary Prevention 01/2020
1	Colostomy 01/2020
1	Intravenous Infusions 01/2019